English
Español
CONTACT US
HOME

ONCOMATRYX

pioneering stromal medicine

Menu

ABOUT
DRUG DISCOVERY
DIAGNOSTICS
COMPANION DX
- COMPANION DIAGNOSTICS
BLOG
CONTACT

PIPELINE

PRECISION DRUGS
ANTIBODY DRUG CONJUGATES
- ADC OMTX705
- ADC OMTX703
PIPELINE

Our first ADC clinical candidate:

UE Next Generation

This company is capitalized by INNVIERTE, AN INVESTMENT PROGRAM OF CDTI, E.P.E.

PRECISION DRUGS

PRECISION DRUGS
ANTIBODY DRUG CONJUGATES
PIPELINE

DIAGNOSTICS

COL11A1 BIOMARKER
INVASIVE TUMOR DIAGNOSTICS -invaScan-
BLADDER CANCER DIAGNOSTICS -bladderScan-

With the collaboration of:

ONCOMATRYX BIOPHARMA SL ©2019

English
Español
TERMS OF USE
PRIVACY POLICY
SITE MAP